课题基金 / 基金详情

Development of Technologies to Facilitate the Use of and Response to Vaccines

Development of Technologies to Facilitate the Use of and Response to Vaccines
开发促进疫苗使用和应对的技术
批准号：
8844784
负责人：
LAURENCE LEMIALE
金额：
$1092.83万
依托单位：
EMERGENT PRODUCT DEVELOPMENT GAITHERSBUR
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
项目状态：
已结题
起止时间：
2012-12-21 至 2015-03-31
来源：
https://reporter.nih.gov/project-details/8844784
关键词：
Advanced DevelopmentAnthrax VaccinesCommunicable DiseasesDevelopmentDisease OutbreaksEventPatientsSupport ContractsTechnologyTranslational ResearchVaccinesbiodefensebiothreatresponsetechnology developmentvaccine delivery

项目摘要

项目成果

LAURENCE LEMIALE的其他基金

相似基金

相关文献

中文摘要
翻译
该合同支持候选产品的高级开发，包括疫苗成分和交付技术，用于故意释放生物威胁剂或自然发生的传染病爆发后的事后环境。这种生物防御疫苗技术旨在简化和加快向大量患者提供疫苗。
英文摘要
This contract supports the advanced development of candidate products, comprised of a vaccine component and a delivery technology, for use in post-event settings following the intentional release of a biothreat agent or naturally occurring outbreaks of infectious diseases. Such biodefense vaccine technologies are intended to simplify and expedite delivery of vaccine to large numbers of patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Technologies to Facilitate the Use of and Response to Vaccines
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N
海外基金